ACHE and early-onset autosomal dominant Alzheimer disease: Pursuing the widespread interest on multi-target drugs to combat Alzheimer ́s disease (AD), a new series of hybrids was designed and developed based on the repositioning of the well-known acetylcholinesterase (AChE) inhibitor, tacrine (TAC), by its coupling to benzofuran (BF) derivatives.